P. Giannakopoulos et al., Differential distribution of presenilin-1, Bax, and Bcl-X-L in Alzheimer'sdisease and frontotemporal dementia, ACT NEUROP, 98(2), 1999, pp. 141-149
We have previously reported that presenilin-1 (PS-1)-immunoreactive neurons
survive in late-onset sporadic Alzheimer's disease (AD). To examine if thi
s is also the case in other dementing conditions, and if it is associated w
ith changes in the expression of the main apoptosis-related proteins, a qua
ntitative immunocytochemical study of presenilin-1, Bar, and Bcl-X-L in the
cerebral cortex of non-demented and AD patients, and patients with frontot
emporal dementia (FTD) was performed. In nondemented cases, the frequency o
f neurons showing PS-1 immunoreactivity was 25-60%, Bar immunoreactivity 36
-54%, and Bcl-X-L immunoreactivity 26-63% depending on the cortical area. T
he frequency of NFT-free neurons which contained PS-1 or Bar was consistent
ly increased in all of the areas in AD. In FTD cases, the percentage of PS-
1-, but not Bax-immunoreactive neurons was increased only in areas displayi
ng a substantial neuronal loss. Conversely, there was no difference in the
densities of Bcl-X-L-containing neurons among the three diagnosis groups. T
hese data suggest that surviving neurons in affected cortical areas in AD s
how a high expression of PS-1 and Bar, indicating that these proteins play
a key role in the mechanisms of cell death in this disorder. In FTD, neuron
s containing PS-1 are preserved, further supporting a neuroprotective role
for this protein in other neurodegenerative disorders.